Public may question experts about disease that mostly affects
Arizonans
SURPRISE, Ariz. - March 15, 2010 - Health care professionals,
epidemiologists and scientists well-versed in Valley Fever will
appear from 5-7 p.m. March 26 on a "Meet the Experts" panel at
Surprise City Hall.
The event is open to the public. Panelists will give brief
presentations about Valley Fever and then open the discussion for
questions. The question-and-answer session will be rebroadcast on
Surprise 11 and online at www.surpriseaz.com/surprise11.
The proposed order of speakers is:
Epidemiology: Peter Kelly, M.D., Arizona Department of Health
Services
Clinical Disease Overview: Janis Blair, M.D., Mayo Clinic
Vaccine and Drug Update: John Galgiani, M.D., Valley Fever Center
for Excellence
Veterinary Update: Michael Matz, D.V.M.
Patient Testimony: Richard Alton, City of Surprise Vice Mayor
The medical name for Valley Fever is coccidioidomycosis, which
often is shortened to cocci (pronounced KOK-SEE), meaning a fungal
infection (mycosis) caused by the fungus Coccidioides.
Valley Fever is prevalent in the hot, desert regions of southern
Arizona, especially in the Phoenix and Tucson areas. The Valley
Fever Center for Excellence at the University of Arizona reports
that an estimated two-thirds of U.S. Valley Fever cases are in
Maricopa, Pinal and Pima counties.
In most cases, the symptoms of Valley Fever are like a mild flu.
Most people who contract the disease do not see a doctor. Symptoms
include fatigue, cough, fever, profuse sweating at night, loss of
appetite, chest pain, and generalized muscle and joint aches
particularly of the ankles and knees.
The "Meet the Experts" presentation is the public portion of the
March 26-27 international meeting of the Coccidioidomycosis Study
Group. Conference organizers include the Translational Genomics
Research Institute (TGen) and Mayo Clinic Arizona.
"Valley Fever is a real concern in Arizona as it affects tens of
thousands of residents every year," said David Engelthaler,
Director of Programs and Operations for TGen North in Flagstaff and
a former Arizona State Epidemiologist. "We are fortunate to have
some of the world's top researchers available here this month to
directly discuss this disease with local citizens."
Also on hand during the March 26 public discussion will be
representatives of the Valley Fever Alliance, which raises funds
and awareness in support of the University of Arizona's Valley
Fever Center For Excellence in their search for a cure, and the
Arizona Victims of Valley Fever. For more information, contact
www.tinyurl.com/valleyfeveralliance.
*
About TGen
The Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. TGen is affiliated
with the Van Andel Research Institute in Grand Rapids, Michigan.
For more information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
# # #